Vivos Inc. Announces Listing to the OTCQB
September 18, 2019 07:00 ET
|
Vivos Inc.
Richland WA, Sept. 18, 2019 (GLOBE NEWSWIRE) -- Vivos Inc. (OTCQB: RDGL), Vivos Inc. a company engaged in the development and commercialization of minimally invasive brachytherapy treatments to...
Vivos Inc. Issues Corrective Press Release Regarding Reverse Stock Split
June 27, 2019 15:07 ET
|
Vivos Inc.
Richland, WA, June 27, 2019 (GLOBE NEWSWIRE) -- Vivos Inc. (the “Company”) (OTC PINK: RDGL), a company engaged in the development and commercialization of minimally invasive brachytherapy...
Vivos Inc. Announces 1-for-8 Reverse Stock Split
June 26, 2019 07:00 ET
|
Vivos Inc.
Richland, WA, June 26, 2019 (GLOBE NEWSWIRE) -- Vivos Inc. (the “Company”) (OTC PINK: RDGL), a company engaged in the development and commercialization of minimally invasive brachytherapy...
Vivos Inc. to Treat Advanced Canine Patient for Soft Tissue Sarcoma with IsoPet®
December 04, 2018 15:50 ET
|
Vivos Inc.
Richland, WA, Dec. 04, 2018 (GLOBE NEWSWIRE) -- Vivos, Inc. (OTC PINK: RDGL) a pharmaceutical company in the process of researching and developing minimally invasive treatments to combat cancer in...
Vivos Inc. Successfully Administers IsoPet® to a Second Dog for Canine Sarcoma at the University of Missouri
October 26, 2018 07:00 ET
|
Vivos Inc.
Richland WA, Oct. 26, 2018 (GLOBE NEWSWIRE) -- Vivos, Inc. (OTC PINK: RDGL) Vivos Inc reported that the second dog in a five-dog series was successfully treated yesterday with Y-90 IsoPet® at the...
Vivos, Inc. Completes Common Stock Equity Financing to Fund Roll Out of IsoPet™ and Eliminate Toxic Debt
October 10, 2018 07:00 ET
|
Vivos Inc.
Richland WA, Oct. 10, 2018 (GLOBE NEWSWIRE) -- Vivos, Inc. (OTC PINK: RDGL) Vivos, Inc. a pharmaceutical company researching and developing minimally invasive treatments to combat cancer in humans...
Vivos Inc Sets the Stage for the Introduction of IsoPet® (RadioGel™) to the Veterinarian Community
August 02, 2018 06:00 ET
|
Vivos Inc.
Richland, WA, Aug. 02, 2018 (GLOBE NEWSWIRE) -- Vivos Inc (OTC: RDGL) finalizes its plan to introduce IsoPet® to the veterinarian community. IsoPet® was designated as a device by the FDA and the...